Hepatitis D in pakistan

Journal of the College of Physicians and Surgeons Pakistan

Volumn 22, Issue 9, 2012, Pages 547-548

  Abbas, Zaigham ^a  

^a SINDH INSTITUTE OF UROLOGY AND TRANSPLANTATION   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; AMINOTRANSFERASE; HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS VACCINE; PEGINTERFERON; PEGINTERFERON ALPHA2A;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY PIERCING; DELTA AGENT HEPATITIS; DEVELOPED COUNTRY; DRUG ABUSE; DRUG EFFICACY; DRUG SAFETY; ENDEMIC DISEASE; GENETIC VARIABILITY; HAIRDRESSER; HEMODIALYSIS; HEPATITIS B; HUMAN; INFECTION RATE; LIVER CIRRHOSIS; MALE HOMOSEXUAL; MIXED INFECTION; PAKISTAN; PREVALENCE; PREVENTIVE HEALTH SERVICE; PROSTITUTION; RURAL AREA; SOUTHERN EUROPE; SUPERINFECTION; TATTOOING; TREATMENT DURATION; VACCINATION; VIREMIA; VIRUS TRANSMISSION;

GENOTYPE; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; INTERFERON-ALPHA; PAKISTAN; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 84866450915     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HU. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J 2010; 16:S15-23.
2. Mumtaz K, Hamid SS, Adil S, Afaq A, Islam M, Abid S, et al. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol 2005; 20:1503-7.
3. Abbas Z, Jafri W, Raza S. Hepatitis D: scenario in the Asia-Pacific region. World J Gastroenterol 2010; 16:554-62.
4. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011; 37:73-85.
5. Seetlani NK, Abbas Z, Raza S, Yakoob J, Jafris W. Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics. J Pak Med Assoc 2009; 59:434-7.
6. Khan AU, Waqar M, Akram M, Zaib M, Wasim M, Ahmad S, et al. True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach. Virol J 2011; 8:420.
7. Memon MS, Zaki M, Ansari K, Abbasi P, Bhatti T, Gill S, et al. Clinical and virological characteristics of hepatitis B and D in chronically infected patients with respect to level of education in Sindh-Pakistan. EASL Monothematic Conference on Delta Hepatitis; Istanbul: September 2010.
8. Mumtaz K, Ahmed US, Memon S, Khawaja A, Usmani MT, Moatter T, et al. Virological and clinical characteristics of hepatitis delta virus in South Asia. Virol J 2011; 8:312.
9. Baig S, Siddiqui AA, Ahmed WU, Qureshi H, Arif A. Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders. J Coll Physicians Surg Pak 2009; 19:699-703.
10. Das K, Ali H, Mahmood T, Munir SM, Ahmed T, Farooq MU. Comparative analysis of disease activity in patients of chronic hepatitis B virus, with and without superinfection with hepatitis D virus; an experience at tertiary care centre. J Ayub Med Coll Abbottabad 2008; 20:39-42.
11. Zuberi BF, Quraishy MS, Afsar S, Kazi LA, Memon AR, Qadeer R, et al. Frequency and comparative analysis of hapatitis D in patients seeking treatment for hepatitis B. J Coll Physicians Surg Pak 2006; 16:581-4.
12. Shaikh MA, Shaikh WM, Solangi GA, Shaikh BA, Soomro MA. Frequency of hepatitis D virus infection in hepatitis B surface antigen-positive liver diseases. J Coll Physicians Surg Pak 2011; 21:23-5.
13. Niro GA, Gioffreda D, Fontana R. Hepatitis delta virus infection: open issues. Dig Liver Dis 2011; 43:S19-24.
14. Moatter T, Abbas Z, Shabir S, Jafri W. Clinical presentation and genotype of hepatitis delta in Karachi. World J Gastroenterol 2007; 13:2604-7.
15. Zaidi G, Idrees M, Malik FA, Amin I, Shahid M, Younas S, et al. Prevalence of hepatitis delta virus infection among hepatitis B virus surface antigen positive patients circulating in the largest province of Pakistan. Virol J 2010; 7:283.
16. Abbas Z, Qureshi M, Hamid S, Jafri W. Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection? Saudi J Gastroenterol 2012; 18:18-22.
17. Abbas Z, Khan MA, Salih M, Jafri W. Interferon alpha for chronic hepatitis D. Cochrane Database Syst Rev 2011;(12):CD006002.
18. Aziz S, Rajper J, Noor-Ul-Ain W, Mehnaz A, Masroor M, Chang MH. Interferon-alpha treatment of children and young adults with chronic hepatitis delta virus (HDV) infection. J Coll Physicians Surg Pak 2011; 21:735-40.
19. Wedemeyer H. Hepatitis D revival. Liver Int 2011; 31:140-4.
20. Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloglu Y, Degertekin H, et al; HIDIT Study Group. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 2011; 364:322-31.